Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Antonelli

Showing results (581-590 of 858) with videos related to

Pageof 86
Sort By:
International Journal of Biological Sciences|July 4, 2025
Acute Exposure to Cadmium Triggers NCOA4-Mediated Ferritinophagy and Ferroptosis in Never-Smokers Oral Cancer CellsLavinia Petriaggi, Emanuele Giorgio, Stefania Bulotta, et al.
Journal of Clinical Medicine|January 11, 2025
Elderly Prostate Cancer Patients Treated with Robotic Surgery Are More Likely to Harbor Adverse Pathology Features and Experience Disease Progression: Analysis of the Prognostic Impact of Adverse Pathology Risk Score Patterns Using Briganti's 2012 Nomogram and EAU Risk GroupsAntonio Benito Porcaro, Emanuele Serafin, Francesca Montanaro, et al.
Oncology Reports|March 9, 2018
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivoSilvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Urolithiasis|December 2, 2022
Validation of the Italian version of wisconsin stone quality of life (WISQOL): a prospective Italian multicenter studyGiorgio Mazzon, Emanuele Serafin, Stefania Ferretti, et al.
Cancers|December 9, 2020
Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational StudySalvatore Sorrenti, Giovanni Carbotta, Filippo Maria Di Matteo, et al.
European Urology Oncology|August 15, 2019
Hypertension and Cardiovascular Morbidity Following Surgery for Kidney CancerUmberto Capitanio, Alessandro Larcher, Francesco Cianflone, et al.
Asian Journal of Andrology|July 30, 2024
Briganti's 2012 nomogram is an independent predictor of prostate cancer progression in EAU intermediate-risk class: results from 527 patients treated with robotic surgeryAntonio Benito Porcaro, Francesca Montanaro, Alberto Baielli, et al.
The Journal of Urology|May 29, 2016
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell CarcinomaAlessandro Larcher, Umberto Capitanio, Carlo Terrone, et al.
Molecular and Cellular Endocrinology|June 17, 2014
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivoAlessandro Antonelli, Guido Bocci, Concettina La Motta, et al.
International Urology and Nephrology|September 28, 2021
Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancerAntonio Benito Porcaro, Alessandro Tafuri, Andrea Panunzio, et al.
Pageof 86

Showing results (581-590 of 858) with videos related to

Sort By:
Pageof 86
International Journal of Biological Sciences|July 4, 2025
Acute Exposure to Cadmium Triggers NCOA4-Mediated Ferritinophagy and Ferroptosis in Never-Smokers Oral Cancer CellsLavinia Petriaggi, Emanuele Giorgio, Stefania Bulotta, et al.
Journal of Clinical Medicine|January 11, 2025
Elderly Prostate Cancer Patients Treated with Robotic Surgery Are More Likely to Harbor Adverse Pathology Features and Experience Disease Progression: Analysis of the Prognostic Impact of Adverse Pathology Risk Score Patterns Using Briganti's 2012 Nomogram and EAU Risk GroupsAntonio Benito Porcaro, Emanuele Serafin, Francesca Montanaro, et al.
Oncology Reports|March 9, 2018
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivoSilvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Urolithiasis|December 2, 2022
Validation of the Italian version of wisconsin stone quality of life (WISQOL): a prospective Italian multicenter studyGiorgio Mazzon, Emanuele Serafin, Stefania Ferretti, et al.
Cancers|December 9, 2020
Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational StudySalvatore Sorrenti, Giovanni Carbotta, Filippo Maria Di Matteo, et al.
European Urology Oncology|August 15, 2019
Hypertension and Cardiovascular Morbidity Following Surgery for Kidney CancerUmberto Capitanio, Alessandro Larcher, Francesco Cianflone, et al.
Asian Journal of Andrology|July 30, 2024
Briganti's 2012 nomogram is an independent predictor of prostate cancer progression in EAU intermediate-risk class: results from 527 patients treated with robotic surgeryAntonio Benito Porcaro, Francesca Montanaro, Alberto Baielli, et al.
The Journal of Urology|May 29, 2016
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell CarcinomaAlessandro Larcher, Umberto Capitanio, Carlo Terrone, et al.
Molecular and Cellular Endocrinology|June 17, 2014
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivoAlessandro Antonelli, Guido Bocci, Concettina La Motta, et al.
International Urology and Nephrology|September 28, 2021
Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancerAntonio Benito Porcaro, Alessandro Tafuri, Andrea Panunzio, et al.
Pageof 86